Skip to main content

Table 1 Patient disposition

From: Assessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE study results

 

n(%)

Total patients enrolled

532

Patients with data at 12 months

305 (57.3)

Patients with data at 24 months

209 (39.3)

Discontinued

237 (44.5)

Reason for discontinuation

 

   Lost to follow-up

73 (13.7)

   Other

65 (12.2)

   Withdrawal of consent

57 (10.7)

   Patient nonadherence

21 (3.9)

   Adverse event

7 (1.3)

   Insufficient response

6 (1.1)

   Death

5 (0.9)

   Patient ineligible to continue trial

2 (0.4)

   Missing

1 (0.2)

Not reported (no notification of discontinuation/no submission of 24-month data)

86 (16.2)